Pediatric Grand Rounds will provide information from the scientific, quality, or public health arenas that may lead to the improvement of child health from an individual, health care system, and/or societal level.
Scott E. Hadland, MD, MPH, MS
Participants will be able to discuss the epidemiology, evidence-based screening and treatment of substance use-related harm in the US, with a focus on adolescents and young adults, and how prescribing opioids in an appropriate manner reduces the likelihood of risk for long-term opioid use and addiction.
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A âfinancial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Please see presentation for bibliographic references.